+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)


Wirelessly Enabled Injection Devices to 2022

  • ID: 4043285
  • Report
  • Region: Global
  • Greystone Associates
1 of 2

For self-administration, adherence with drug therapy and disease management protocols has become a primary concern within the healthcare and pharmaceutical industries. For chronic conditions adherence has a direct effect on the patient’s quality-of-life.

Wirelessly enabled devices - drug injection devices that are designed to address the patient adherence issue by reminding and recording data about patient dosing activity and making it available to HCPs - are gaining interest among industry and managed care participants. Efforts to enhance adherence have a non-negligible effect on drug formulations and delivery decisions, and are a significant factor in the prescribing decisions of most physicians. The connected device ecosystem includes OEM device suppliers, drug developers, human factors consultants and aftermarket third-party devices.

Wirelessly Enabled Injection Devices - What You Will Learn

  • What drug injection devices incorporate wireless connectivity technology, how do they work and what new capabilities do they offer to patients and their HCPs?
  • What benefits do wirelessly enabled drug injectors provide to patients in the area of improved adherence? Patient reported outcomes? HCP/patient communication?
  • What therapeutic areas are the current focus of wirelessly enabled devices?
  • Who are the companies behind the growth of wirelessly enabled injection devices? What are their development activities and corporate alliances and affiliations
  • What is the importance of pharma-device alliances and design partnerships on wirelessly enabled drug injection device commercialization and market access?
  • What does the current market for wirelessly enabled drug injection devices look like? What will it look like in 2022?
  • What are the key market drivers for the growth of wirelessly enabled injection devices?

Report Value Chain - Who Should Read this Report


  • Drug Developers
  • Device Suppliers
  • CMOs
  • Components/APIs
  • Testing/Validation
  • Clinical Trial Mgmt


  • Pharma Managers
  • Biotech Managers
  • Drug Marketers
  • Industry Strategists
  • Financial Analysts
  • Management


  • Clinical Managers
  • Drug Distributors
  • Pharma Regulators
  • FDA Consultants
  • Managed Care Managers Consultants
Note: Product cover images may vary from those shown
2 of 2

1. Executive Summary

2. Wireless Injection Devices - The Opportunity

3. Injectable Device Technology

  • Market Drivers
  • The Growth of Self-Administration
  • The Rise in Home Healthcare
  • The Cost of Non-Adherence
  • Biological Injectables and Patient Safety
  • The Impact of Developing Economies

4. Connectivity Technologies

  • Wireless Technologies
  • Bluetooth
  • Cellular
  • Near Field Communications
  • RFID

5. Wirelessly Enabled Device Classes

  • Wearable Devices
  • Handheld Devices
  • Device Segments
  • Non-drug Specific Connected Injectors
  • Automated Connected Injectors
  • Vendor-specific Connectivity Platforms
  • Third Party Connectivity Devices

6. Near-term Markets for Connected Injection Devices

  • Anaphylaxis
  • Autoimmune Disease
  • Cardiovascular
  • Diabetes
  • Hormone Replacement

7. Market Factors

  • Regulatory Issues
  • HIPAA and Patient Privacy
  • Data Security
  • Cybersecurity and Patient Safety
  • Patient Safety
  • User Training

8. Company Profiles

Note: Product cover images may vary from those shown
3 of 2